Paladin Labs Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

November 2024 | 50 pages | ID: PBCFBF00417BEN
BAC Reports

Abstracts

Paladin Labs Inc. Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quarterly forecasts made by stock market experts. The report also enables direct comparison to be made between Paladin Labs Inc. and its competitors. This provides our Clients with a clear understanding of Paladin Labs Inc. position in the Pharmaceuticals and Biotechnology Industry.

• The report contains detailed information about Paladin Labs Inc. that gives an unrivalled in-depth knowledge about internal business-environment of the company: data about the owners, senior executives, locations, subsidiaries, markets, products, and company history.
• Another part of the report is a SWOT-analysis carried out for Paladin Labs Inc.. It involves specifying the objective of the company's business and identifies the different factors that are favorable and unfavorable to achieving that objective. SWOT-analysis helps to understand company’s strengths, weaknesses, opportunities, and possible threats against it.
• The Paladin Labs Inc. financial analysis covers the income statement and ratio trend-charts with balance sheets and cash flows presented on an annual and quarterly basis. The report outlines the main financial ratios pertaining to profitability, margin analysis, asset turnover, credit ratios, and company’s long-term solvency. This sort of company's information will assist and strengthen your company’s decision-making processes.
• In the part that describes Paladin Labs Inc. competitors and the industry in whole, the information about company's financial ratios is compared to those of its competitors and to the industry. The unique analysis of the market and company’s competitors along with detailed information about the internal and external factors affecting the relevant industry will help to manage your business environment. Your company’s business and sales activities will be boosted by gaining an insight into your competitors’ businesses.
• Also the report provides relevant news, an analysis of PR-activity, and stock price movements. The latter are correlated with pertinent news and press releases, and annual and quarterly forecasts are given by a variety of experts and market research firms. Such information creates your awareness about principal trends of Paladin Labs Inc. business.

About Paladin Labs Inc.

Paladin Labs Inc., a specialty pharmaceutical company, focuses on the development, acquisition, in-licensing, marketing, and distribution of pharmaceutical products in Canada and internationally.

Impavido: Impavido is a treatment for leishmaniasis. Impavido is the oral medication for leishmaniasis, a disease commonly found in the developing world.

Unisom and Kaopectate: The company owns two OTC brands, Unisom and Kaopectate.

Dexedrine: Dexedrine is used to treat attention deficit hyperactivity disorder and narcolepsy.

Sancuso: It is a transdermal patch that delivers granisetron, an established 5HT3 receptor antagonist, and is indicated for the prevention of nausea and vomiting in patients undergoing chemotherapy for approximately 5 consecutive days. Sancuso is approved in the United States.

Abstral: It is a dissolving, sub-lingual tablet of fentanyl, indicated for the management of breakthrough cancer pain in patients who are already receiving opioid analgesics. Abstral is approved in Sweden, Denmark, United Kingdom and Germany.

Seasonale: SEASONALE addresses two primary needs: provide contraception, andminimize the number of periods per year from 13 to 4 (one per season). Paladin and Procter & Gamble Pharmaceuticals Canada, Inc. entered a co-promotion agreement for its Canadian sales.

Testim: It is a topical testosterone gel indicated for testosterone replacement therapy in adultmales.

Trelsta: Trelstar is an injectable luteinizing hormone-releasing agonists (LHRH), bolster both the company’s urology and women’s health franchises as they are indicated for the palliative treatment of prostate cancer and endometriosis.

Tridural: It is a drug indicated for moderately severe pain.

Metadol: It is an opioid analgesic. Indicated for the relief of severe pain (acute cancer pain, chronic pain disorders, and for palliative care).

Pennsaid: It is a topical, non-steroidal anti-inflammatory (NSAID), used for the treatment of osteoarthritis of the knee.

The company owns BioEnvelop Inc., which has expertise in developing and manufacturing rapidly dissolving edible films. It owns ViRexx Medical Corp., which is a Canadian based biotech company developing hepatitis Band Cvaccines and products to treat liver, ovarian and other cancers. The company owns Virexx Medical Corp., a Canadian-based biotech company focused on developing innovative-targeted therapeutic products.

Agreements

The company has a license and distribution agreement with Duramed Pharmaceuticals for Seasonique, the next generation of extended-cycle oral contraceptives. Paladin holds the right to license and market SEASONIQUE in Canada.

Significant Events

On June 18, 2009, Paladin Labs Inc. and Sylphar N.V. announced that they have entered into an agreement to develop and market an oral dissolving teeth whitening film strip in Europe.

History

Paladin Labs Inc. was founded in 1983.

The above Company Fundamental Report is a half-ready report and contents are subject to change.
It means that we have all necessary data in our database to prepare the report but need 2-3 days to complete it. During this time we are also updating the report with respect to the current moment. So, you can get all the most recent data available for the same price. Please note that preparation of additional types of analyses requires extra time.

Contents

RESEARCH METHODOLOGY

DISCLAIMER

1. PALADIN LABS INC. COMPANY PROFILE

1.1. Key facts
1.2. Financial Performance
1.3. Key Executives
1.4. Ownership and Major Holders
1.5. Company History

2. PALADIN LABS INC. BUSINESS OVERVIEW

2.1. Business Description
2.2. Major Products and Services
2.3. Markets and Sales Activities
2.4. Locations, Subsidiaries, Operating Units

3. PALADIN LABS INC. SWOT ANALYSIS

3.1. Overview
3.2. Strengths
3.3. Weaknesses
3.4. Opportunities
3.5. Threats

4. PALADIN LABS INC. FINANCIAL ANALYSIS

4.1. Financial Statements
4.1.1. Income Statement
4.1.2. Balance Sheet
4.1.3. Cash Flow
4.2. Financial Ratios
4.2.1. Profitability
4.2.2. Margin Analysis
4.2.3. Asset Turnover
4.2.4. Credit Ratios
4.2.5. Long-Term Solvency
4.2.6. Growth Over Prior Year
4.2.7. Financial Ratios Charts
4.3. Stock Market Snapshot

5. PALADIN LABS INC. COMPETITORS AND INDUSTRY ANALYSIS

5.1. Paladin Labs Inc. Direct Competitors
5.2. Comparison of Paladin Labs Inc. and Direct Competitors Financial Ratios
5.3. Comparison of Paladin Labs Inc. and Direct Competitors Stock Charts
5.4. Paladin Labs Inc. Industry Analysis
5.4.1. Pharmaceuticals and Biotechnology Industry Snapshot
  5.4.2. Paladin Labs Inc. Industry Position Analysis

6. PALADIN LABS INC. NEWS & EVENTS

6.1. News & PR Activity Analysis
6.2. IR Corporate News
6.3. Marketing News
6.4. Corporate Events

7. PALADIN LABS INC. EXPERTS REVIEW¹

7.1. Experts Consensus
7.2. Experts Revisions

8. PALADIN LABS INC. ENHANCED SWOT ANALYSIS²

9. CANADA PESTEL ANALYSIS²

9.1. Political Factors
9.2. Economic Factors
9.3. Social Factors
9.4. Technological Factors
9.5. Environmental Factors
9.6. Legal Factors

10. PALADIN LABS INC. IFE, EFE, IE MATRICES²

10.1. Internal Factor Evaluation Matrix
10.2. External Factor Evaluation Matrix
10.3. Internal External Matrix

11. PALADIN LABS INC. PORTER FIVE FORCES ANALYSIS²

12. PALADIN LABS INC. VRIO ANALYSIS²

APPENDIX: RATIO DEFINITIONS

LIST OF FIGURES

Paladin Labs Inc. Annual Revenues in Comparison with Cost of Goods Sold and Gross Profit
Profit Margin Chart
Operating Margin Chart
Return on Equity (ROE) Chart
Return on Assets (ROA) Chart
Debt to Equity Chart
Current Ratio Chart
Paladin Labs Inc. 1-year Stock Charts
Paladin Labs Inc. 5-year Stock Charts
Paladin Labs Inc. vs. Main Indexes 1-year Stock Chart
Paladin Labs Inc. vs. Direct Competitors 1-year Stock Charts
Paladin Labs Inc. Article Density Chart

1 – Data availability depends on company’s security policy.
2 – These sections are available only when you purchase a report with appropriate additional types of analyses.
The complete financial data is available for publicly traded companies.

List Of Tables

LIST OF TABLES

Paladin Labs Inc. Key Facts
Profitability
Management Effectiveness
Income Statement Key Figures
Balance Sheet Key Figures
Cash Flow Statement Key Figures
Financial Performance Abbreviation Guide
Paladin Labs Inc. Key Executives
Paladin Labs Inc. Major Shareholders
Paladin Labs Inc. History
Paladin Labs Inc. Products
Revenues by Segment
Revenues by Region
Paladin Labs Inc. Offices and Representations
Paladin Labs Inc. SWOT Analysis
Yearly Income Statement Including Trends
Income Statement Latest 4 Quarters Including Trends
Yearly Balance Sheet Including Trends
Balance Sheet Latest 4 Quarters Including Trends
Yearly Cash Flow Including Trends
Cash Flow Latest 4 Quarters Including Trends
Paladin Labs Inc. Profitability Ratios
Margin Analysis Ratios
Asset Turnover Ratios
Credit Ratios
Long-Term Solvency Ratios
Financial Ratios Growth Over Prior Year
Paladin Labs Inc. Capital Market Snapshot
Paladin Labs Inc. Direct Competitors Key Facts
Direct Competitors Profitability Ratios
Direct Competitors Margin Analysis Ratios
Direct Competitors Asset Turnover Ratios
Direct Competitors Credit Ratios
Direct Competitors Long-Term Solvency Ratios
Pharmaceuticals and Biotechnology Industry Statistics
Paladin Labs Inc. Industry Position
Company vs. Industry Income Statement Analysis
Company vs. Industry Balance Sheet Analysis
Company vs. Industry Cash Flow Analysis
Company vs. Industry Ratios Comparison
Paladin Labs Inc. Consensus Recommendations¹
Analyst Recommendation Summary¹
Price Target Summary¹
Experts Recommendation Trends¹
Revenue Estimates Analysis¹
Earnings Estimates Analysis¹
Historical Surprises¹
Revenue Estimates Trend¹
Earnings Estimates Trend¹
Revenue Revisions¹

ANALYSIS FEATURES

SWOT Analysis

SWOT, which stands for Strengths, Weaknesses, Opportunities and Threats, is an analytical framework that identifies the internal and external factors that are favorable and unfavorable for a company.

Enhanced SWOT Analysis

Enhanced SWOT is a 3×3 grid that arranges strengths, weaknesses, opportunities and threats into one scheme:

• How to use the strengths to take advantage of the opportunities?
• How to use the strengths to reduce likelihood and impact of the threats?
• How to overcome the weaknesses that obstruct taking advantage of the opportunities?
• How to overcome the weaknesses that can make the threats a reality?

Upon answering these questions a company can develop a project plan to improve its business performance.

PESTEL Analysis

PESTEL (also termed as PESTLE) is an ideal tool to strategically analyze what influence different outside factors – political, economic, sociocultural, technological, environmental and legal – exert on a business to later chart its long term targets.

Being part of the external analysis when carrying out a strategic assessment or performing a market study, PESTEL gives an overview of diverse macro-environmental factors that any company should thoughtfully consider. By perceiving these outside environments, businesses can maximally benefit from the opportunities while minimizing the threats to the organization.

Key Factors Examined by PESTEL Analysis:

• Political – What opportunities and pressures are brought by political bodies and what is the degree of public regulations’ impact on the business?
• Economic – What economic policies, trends and structures are expected to affect the organization, what is this influence’s degree?
• Sociological – What cultural and societal aspects will work upon the demand for the business’s products and operations?
• Technological – What impact do the technological aspects, innovations, incentives and barriers have on the organization?
• Environmental – What environmental and ecological facets, both locally and farther afield, are likely to predetermine the business?
• Legal – What laws and legislation will exert influence on the style the business is carried out?

IFE, EFE, IE Matrices

The Internal Factor Evaluation matrix (IFE matrix) is a strategic management tool helping audit or evaluate major weaknesses and strengths in a business’s functional areas. In addition, IFE matrix serves as a basis for identifying and assessing relationships amongst those areas. The IFE matrix is utilised in strategy formulation.

The External Factor Evaluation matrix (EFE matrix) is a tool of strategic management that is typically utilised to assess current market conditions. It is an ideal instrument for visualising and prioritising the threats and opportunities a firm is facing.

The essential difference between the above mentioned matrices lies in the type of factors incorporated in the model; whilst the latter is engaged in internal factors, the former deals exceptionally with external factors – those exposed to social, political, economic, legal, etc. external forces.

Being a continuation of the EFE matrix and IFE matrix models, the Internal External matrix (IE matrix) rests upon an investigation of external and internal business factors integrated into one suggestive model.

Porter Five Forces Analysis

The Porter’s five forces analysis studies the industry of operation and helps the company find new sources of competitive advantage. The analysis surveys an industry through five major questions:

1. What composes a threat of substitute products and services?
2. Is there a threat of new competitors entering the market?
3. What is the intensity of competitive rivalry?
4. How big is the bargaining power of buyers?
5. How significant is the bargaining power of suppliers?

VRIO Analysis

VRIO stands for Value, Rarity, Imitability, Organization. This analysis helps to evaluate all company’s resources and capabilities and bring them together into one aggregate table that includes:

• Tangible resources
  • Financial
  • Physical
  • Technological
  • Organizational
• Intangible resources
  • Human
  • Innovation and Creativity
  • Reputation
• Organizational capabilities

The result of the analysis gives a clear picture of company’s competitive and economic implications, answering the questions if the resources mentioned above are:

• Valuable?
• Rare?
• Costly to imitate?
• Organized properly?